The purpose of this investigation was to study the hemodynande correlates of exercise function in patients with primary pulmonary hypertension and to further define the role of exercise testing in the evaluation of these individuals . Beta from the progressive exercise tests and subsequent cardiac catheterization in 16 consecalive patients, aged 16,9 ± 10 .4 years (range 6 to 35), with primary pulmonary hypertension were prospectively collected and analyzed. Exercise capacity averaged 40 x 36% (range 0 to 117%) of that predicted for age, height and gender .
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The purpose of this investigation was to study the hemodynande correlates of exercise function in patients with primary pulmonary hypertension and to further define the role of exercise testing in the evaluation of these individuals . Beta from the progressive exercise tests and subsequent cardiac catheterization in 16 consecalive patients, aged 16,9 ± 10 .4 years (range 6 to 35), with primary pulmonary hypertension were prospectively collected and analyzed. Exercise capacity averaged 40 x 36% (range 0 to 117%) of that predicted for age, height and gender .
Statistically significant correlations existed between exercise capacity and t0 Imitatively measured hemodynamic variables . Mean right atria) pressure, a variable previously noted to be one of the best predictors of survival in patients with primary pulmo • Dyspnea is one of the earliest and most common clinical features of primary pulmonary hypertension (1-4). Early in the course of the disease, shortness of breath is noted only during relatively vigorous exercise . Later, dyspnea becomes progressive and occurs with even mild exertion . Eventually, the patient's ability to exercise becomes severely limited (2,3) . Although the exercise capacity of patients with primary pulmonary hypertension has been noted to roughly parallel the severity of pulmonary vascular obstruction (5), the exact relation between exercise performance and hemodynamic variables measured at cardiac catheterization has not been evaluated .
The purpose of this study was to prospectively determine the relation between the clinical manifestations, cardiac catheterizalion data and exercise capacity of patients with primary pulmonary hypertension and to further establish the role of exercise testing in the noninvasive assessment of these patients.
From the Division at Pediatric Cardiology, Babies Hospital, ColombiaPresbyterian Medical Center . New York. New York. This study was presented in part at the 39th Annual Meeting of the American College of Cardiology, March 1990. nary hypertension, correlated best with exercise capacity (r = -0.83, p < 0.0001). Exercise capacity >75% of the predicted value identified the two patients who had a positive response to acute pulmonary vasodilator drug testing . Poor exercise capacity (<10% of the predicted value) Identified the three patients who died during or soon after cardiac catheterizalion.
The ability of exercise leading to tdemlfy patients at high risk for cardiac calbeleriration was superior to that of other nonlnvasive variables . Results of exercise testing may help guide decisions regarding the optimal timing of heart-lung or single lung transplantation.
(J Am Coll Cadiot 1991 ;18:1 .38-44)
Methods
Study patients. The study group consisted of 16 consecutive patients with documented or suspected primary pulmonary hypertension referred to Columbia Presbyterian Medical Center between April 1987 and December 1989 for cardiac catheterization and acute pulmonary vasodilator drug testing . The patients ranged in age from 6 to 35 years (mean 16.9 ± 10 .4) ; four were male and 12 female, Three patients from two separate pedigrees had familial primary pulmonary hypertension ; the remainder had sporadic primary pulmonary hypertension . None of these patients had structural heart anomalies, evidence of pulmonary thromboembolic phenomena (on the basis of ventilation-perfusion scans) or significant parenchymal lung disease (on the basis of chest X-ray study and pulmonary function tests) .
Eight patients were receiving no medication at the time of the study . Eight others were maintained on one or more of the following medications : digoxin, diuretic drugs, nifedipine, warfarin and phenoxybenzamine . One woman received supplemental oxygen and long-term intravenous prostacydin therapy .
One child with familial primary pulmonary hypertension was asymptomatic at the time of the study (New York Heart Association functional class 1), six patients had symptoms corresponding to functional class II, four were in class 111 and five were in class IV .
Exercise protocol. All patients performed a standard progressive bicycle ergometry test (6). They were instructed to 0775-11197M1lllxl.5n maintain a pedaling rate of 60 rpm . During an initial 3-min warm-up work load, patients pedaled against 0 resistance . The work load was then increased by increments of 20 Wlmin (10 W!'min for patients < 120 em in height or those who by history had severely limited exercise capacity, or both) until the 60-rpm rate could no longer be maintained . The work load at which the 60-rpm pedaling rate could not be maintained was defined as the patient's peak work load . Exercise capacity . defined as the percent of predicted peak work load achieved, was calculated using standard equations (7, 8) .
Throughout the exercise test, each patient's heart rate and electrocardiogram (ECG) were monitored on a Quinton Status 1000 recorder . Oxygen saturation was monitored with a Nellcor N200 pulse oximeter and blood pressure was measured each minute with an appropriate-sized cuff.
Other noninvasive measurements . Before the exercise test, each patient had a chest X-ray study . ECG (standard 2 leads and V 0 R) and two-dimensional and Doppler echocardiograms. Cardiomegaly was diagnosed if the cardiothoeacic ratio was >0.5 on a posteroanterior chest X-ray film . Right ventricular strain was diagnosed according to the criteria of Park and Guntheroth (9) . The echocardiographic method of King et al. (10) was used to diagnose the presence of posterior systolic bowing of the interventricular septum . Doppler ultrasound was used to measure the pulmonary acceleration time and to diagnose the presence of valvulur regurgitation .
Cardiac catheterization . Cardiac catheterization was performed on each patient I or 2 days after exercise testing and noninvasive studies . Digoxin and diuretic agents were withheld on the day before catheterization . All patients were premeditated with meperidine, promethazine and scopolamine . Five of the most symptomatic patients received supplemental oxygen during cardiac catheterization .
Right-sided pressures were recorded wide a Swae-Gauz catheter . In two patients, it was not possible to advance the catheter into the pulmonary artery ; in these patients, right ventricular systolic pressure was assumed to be equal to systolic pulmonary artery pressure . In one of these patients, left ventricular end-diastolic pressure was measured and assumed to be roughly equivalent to the mean pulmonary capillary wedge pressure . Systemic arterial pressure and oxygen saturation were measured with an indwelling arterial catheter . In 10 patients, cardiac output was determined by the thermedilution method (mean of three measurements) . In six patients with severe tricuspid or pulmonary valve regurgitation, or both, cardiac output was calculated with the Fick equation . Standard equations were used to calculate pulmonary vascular resistance, systemic vascular resistance and stroke volume . All flow, volume and resistance measurements were normalized for body surface area .
Drug testing . Fourteen of the 16 patients underwent acute vasodilator drug testing with intravenous prostacyclin during cardiac catheterization . Acute pulmonary vasoreactivity was evaluated because empiric treatment with vasodi-RHODES ET \L .
EXERCISE FL SCTION IN PULMONARY HYPERTENSION
Hers may be deleterious if given to patients with fixed pulmonary vascular disease (I1 .12) . Nine of these patients also underwent sub equent short-term testing with nifedipvtc {oral or sublingual) and either intravenous prostaglandin E, or phentolamrne, or both . Details of the vasodilator test . . ., methods have been published previously (11). Va . sodilators were not administered to two patients who manifested hemodynamic instability .
Statistical analysis . Statistical analyses were performed with an Apple Macintosh computer using the StatView statistics program !Abacus Concepts) . Univariate and multivariate analyses were used to examine the relation between exercise capacity and each of tht hemodynamic variables studied . Student's r test for paired samples was used to analyze the patients' responses to vasodilators and Student's unpaired t test to compare the hemodyuamics of subgroups of patients with primary pulmonary hypertension . Fisher's exact test was used to assess the ability of noninvasive variables to identify patients at high risk during cardiac catheterzation, Data arc presented as mean values t SD .
Results
Exercise capacity data (Table 1 . Fig . 1 ) . Four patients could not exercise beyond the initial 0-resistance warm-up period and were assigned an exercise capacity of 0% . The exercise capacity of the remaining 12 patients ranged from 13% to 117% of the predicted value : 2 were able to exercise to >75% of their predicted value . The exercise capacity of the entire series of patients averaged 40 ± 36% of the predicted capacity . No complications occurred during the exercise tests .
Baseline hemodynamic data (Table 1 ) . All patients had moderate to severe pulmonary hypertension . Mean pulmonary artery pressure was 59 t t1 mm Hg and pulmonary vascular resistance index averaged 26 ± 17 units.mc . Mean right atrial pressure was mildly elevated (8 t 7 mm Hg) and cardiac index was slightly below normal (2 .3 . 0 .9literslmin per m') . The average mean pulmonary capillary wedge pressure was in the normal range (7 ± 5 mm Hg) ; it was >10 mm Hg in two patients . Mean right atrial pressure and pulmonary capillary wedge pressure in patients who had received diuretic drugs did not differ from values in patients who had not received diuretic therapy .
Correlation of exercise capacity and hemodynamic varia. bles (Tables 1 and 2 ). The strongest correlation by univariate analysis was the negative relation between exercise capacity and mean right atria] pressure (Fig . 2) . Statistically significant negative correlations also existed between exercise capacity and pulmonary artery systolic, diastolic and mean pressures . pulmonary vascular resistance, systemic vascular resistance, the pulmonary/systemic vascular resistance ratio and the ratio of the pulmonary to systemic systolic pressure . A statistically significant positive correlation existed between exercise capacity and cardiac index and stroke volume index . The relation between exercise capacity and mean IACC Val. 'These three patient, died during or soon after cardiac cathcleriaarion . C1 = cardiac index ; Dias =diastolic: EC =exercise capacity : PAIAu = pulmonary to systemic systolic pressure ratio ; PCWP= pulmonary capillary wedge pressure : peed = predicted ; Pt= patient ; PVRI =pulmonary vascular resistance index ; PVRJSVR = pulmonary to systemic vascular resistance ratio: RAP = right atrial pressure ; SVI = stroke volume index ; SVRI = systemic vascular resistance index ; Spa = systolic. pulmonary capillary wedge pressure did not achieve statistical significance .
When Jnoltivariate analysis was applied to the data, the mean right atrial pressure and the pulmonary/systemic vascular resistance ratio emerged as the only hemodynamic variables independently related to exercise capacity (p < 0 .05) ( Table 2) , Hemodynamic response to short-term prostacyclin administration (Table 3) . Prostacyclin increased cardiac index and decreased pulmonary and systemic vascular resistance in each of the 14 patients studied . At the dose of prostacyclin Exercise Capacity (% predicted) that resulted in the greatest decrease in pulmonary vascular resistance, the deviations in these variables from baseline values were highly significant (p < 0 .001) . In contrast, the effect of prostacyclin on mean pulmonary artery pressure and pulmonarylsystemic vascular resistance ratio varied from patient to patient and the deviations from baseline did not achieve statistical significance. Exercise capacity did not correlate with prostacyclin-induced changes in any of these variables. Two of the 14 patients studied were classified as vasodilator responders, according to the criteria of Rich (3) (that is, a22% decrease in pulmonary artery pressure associated with ?36% decrease in pulmonary vascular resistance and a decrease in the pulmonary/systemic vascular resistance ra- tio) . None of the other patients displayed this capacity for active selective pulmonary vasodilation . The two vasodilator responders were the same patients whose exercise capacity was >75% of the predicted value (p < 0 .05) .
Comparisons between patients who could or could not exercise (Table 4 ). The hemodynamic findings in the four patients who were unable to exercise beyond the initial 0-resistance warm-up work load (Group II were compared with those who could exercise beyond that level (Group Il) . Group I patients tended to have a lower cardiac index and higher resistance and filling pressure than did their counterparts in Group 11 .
During the initial phases of cardiac catheteriznrirnt, before the administration of angiographic medium or vasodilators, two of the four patients in Group I developed hypotension and bradycardia associated with an acute severe increase in pulmonary vascular resistance . One of these patients subsequently had a complete cardiopulmonary arrest and died in the catheterization laboratory . The condition of the other patient was stabilized, and she was electively intubated and transferred to the pediatric intensive care unit . Her condition progressively deteriorated and she died 48 h after cardiac catheterization . A third patient completed the cardiac catheterization and short-term vasodilator drug testing, but developed hypetension associated with a junctional -s 25 Hence, only one of the four patients who were unable to exercise survived beyond the early postcardiac catheterization period. In contrast, none of the 12 patients whose exercise capacity was >10% of the predicted value (Group III died or had a serious complication during cardiac catheterization or pulmonary vasodilator drug testing . The inability to exercise was therefore a sensitive (sensitivity 100%) and specific (specificity 92%) predictor of mortality risk during cardiac catheterization .
Comparison between exercise testing and other noninvasive techniques with regard to the prediction of catheterizationrelated death (Table 5 ) . The inability to exercise was the best predictor of catheterization-related death (p < 0 .01). New York Heart Association functional class IV categorization also identified these patients (sensitivity 100%, specificity 83%, p < 0.05). No other noninvasive variable accurately predicted death during cardiac catheterization .
Discussion
Predictive accuracy of poor exercise capacity in primary pulmonary hypertension . Our results indicate that poor exercise capacity predicts severe hemodynamic abnormalities . as measured during cardiac catheterization, among patients with primary pulmonary hypertension . This observation is consistent with past investigations, in a slightly older group of patients, that have indicated an association between hemodynamic aberrations and poor exercise function . In a study of nine patients with pulmonary hypertension of various origins. Janicki et al. (5) found that patients whose puicronary vascular resistance was >1,000 dynes-s-em -s
(1'_ .5 Woods units) had a lower maximal oxygen consumption and could not exercise as long as patients whose pulmonary vascular resistance was <1,000 dynes'scm -s. The exercise capacity of the patients with pulmonary hypertension was less than that of four patients with a normal pulmonary artery pressure . D'Alonzo et al. (13) reported that maximal oxygen consumption in a group of I1 patients with primary pulmonary hypertension averaged 40% of the predicted value, a value -Deviation from baseline smlolically sigmficant (p C (I. "PI), Data prescnld as mean _ SD Image in parentheses) . Abbreviations as in Table I Table I. corresponding to the 40% of predicted exercise capacity achieved by patients in our study . They (13) also observed that the patient's anaerobic threshold occurred at a much lower oxygen consumption than that of normal control subjects and that the anaerobic threshold correlated well with maximal oxygen pulse (a rough noninvasive estimate of maximal stroke volume) . However, no attempt was made to correlate exercise capacity with invasively measured hemodynamic variables . In a separate study of 10 patients with primary and thromboembolic pulmonary hypertension, D'Alonzo et al. (14) reported that changes in total pulmonary resistance in response to an 8-week course of vasodilator therapy correlated well with concomitant changes in maximal oxygen consumption and oxygen pulse . However, the relation between exercise capacity and the absolute level of total pulmonary resistance was not evaluated . Correlation of exercise capacity and right atrial pressure . In addition to supporting the results of previous investigators, our data prospectively quantified the relation between exercise capacity and hemodysamics in patients with primary pulmonary hypertension . One of the key findings in our analysis was the strong negative correlation between exercise capacity and mean right atrial pressure . Elevation of mean right atria] pressure reflects right ventricular decompensation in the presence of increased afterload imposed by pulmonary vascular disease . Under these circumstances, the ability of the right ventricle to adapt to the additional hemodynamic demands of exercise is limited. This factor appears to contribute significantly to the deterioration of the patient's exercise capacity .
Earlier investigations (15-17) have found mean right atria[ pressure to be one of the best predictors of survival in patients with primary pulmonary hypertension . The close association between exercise capacity and right atrial pressure documented in the current study suggests that exercise testing data can be used to noninvasively estimate the life expectancy of patients with primary pulmonary hypertension. This information could be used to help guide decisions regarding the optimal timing for heart-lung or single lung transplantation .
Correlation of exercise capacity and response to vasodilator administration . Our data also provide information about the relation between exercise function and the response to acute IACC Vol. 18 . No . 7 vasodilator administration . In a normal subject, exercise is associated with a large increase in pulmonary blood flow, This increase is accommodated by recruitment of blood vessels ordinarily closed at rest and by distension of blood vessels already open . Pulmonary artery and left atrial pressures may increase, but the transpulmonary gradient remains relatively constant; pulmonary vascular resistance, therefore, decreases during exercise (18). The degree to which these functions of the pulmonary vascular bed are impaired varies among patients with primary pulmonary hypertension (19) and may be a causal factor in the severity of their symptoms. If the capacity to achieve pulmonary vasodilation in response to pharmacologic agents corresponds to the ability to lower pulmonary vascular resistance during exercise, the exercise capacity of patients with primary pulmonary hypertension who respond favorably to vasodilators should exceed that of patients who do not possess this capacity . Surprisingly, our data did not reveal a statistically significant association between exercise capacity and the decrease in pulmonary vascular resistance in response to acute administration of prostacyclin . This paradox may be explained by the fact that a decrease in pulmonary vascular resistance was rarely associated with a significant decline in mean pulmonary artery pressure or the pulmonary/systemic vascular resistance ratio. Others (20) have noted that a poor December 1991 MRcorrelation exists between survival and the magnitude of acute vasodilator-induced decrease in pulmonary vascular resistance and have questioned the clinical significance of a decrease in pulmonary vascular resistance that is unaccompanied by a simultaneous decrease in the mean pulmonary artery pressure or pulmonarylsystemic vascular resistance ratio (3, 11, 20 ,2 1) . In light of these considerations . the poor correlation between exercise capacity and the prostacyclininduced decrease in pulmonary vascular resistance is understandable .
The two patients in this study who achieved the best exercise test results (exercise capacity >75a, of the predicted value) were the only patients to manifest a positive response to prostacyclin (that is . ?22% decrease in mean pulmonary artery pressure associated with ~36h decrease in pulmonary vascular resistance and a decrease in the pulmonarylsystemie vascular resistance ratio). This finding once again emphasizes the clinical importance of the distinction between "active pulmonary vasodilation" and the nonspecific "passive pulmonary vasodilation" (that is . a decrease in pulmonary vascular resistance unaccompanied by a decrease in pulmonary artery pressure and the pulmonary" systemic vascular resistance ratio) manifested by the majority of patients with primary pulmonary hypertension (3, 11, 18, 21) . Furthermore, patients who have had a positive response to acute pulmonary vasodilator testing are more likely to have a good clinical response to long-term oral vasodilator therapy (11,21) . Therefore, we speculate that exercise testing may assist in identifying the patients with primary pulmonary hypertension who are most likely to benefit from long-term vasodilator therapy .
Risk of cardiac eatheterization . Past studies (1,2,22 23) have reported that patients with primary pulmonary hypertension have a relatively high mortality risk during cardiac catheterization. The three deaths in our present series reemphasize the fragile nature of these patients. The National Institutes of Health prospective study (4) of primary pulmonary hypertension, however, reported no deaths during cardiac catheterization in 187 patients . Our series differs from that study in that many of our patients were referred for acute vasodilator drug testing after having failed standard treatment regimens . It is, therefore, likely that their vascular disease was more advanced than that of the typical patient with primary pulmonary hypertension at initial presentation . This factor may account for some of the discrepancy bePveen the National Institutes of Health study and our series .
The inability to exercise beyond the initial 0-resistance warm-up work load emerged as a clinically useful variable in the precatheterization assessment of patients with primary pulmonary hypertension . This feature identified each of the three patients who died during or soon after cardiac catheterization . Patients who could exercise Inc example, those whose exercise capacity was >IOO, of the predicted value) tolerated catheterization without complication . No other noninvasive variable identified the patients at greatest risk ESERCISF Ft Ncr!vx IN PULMONARY HYPERTENSION during cardiac catheterization with such a high degree of sensitivity and specificity .
Patients who were unable to exercise also tended to have the most severe htmodynamic derangements . Such patients arc unlikely to have a positive response to conventional vasodilators (3) . Therefore . we believe that for the patient with primary pulmonary hypertension and extremely limited exercise capacity, the risk of cardiac catheterization outweighs the small chance that information derived from the procedure would enable the patient's physician to devise an effective conventional vasodilator regimen . Consequently, we recommend that exercise capacity be assessed to help identify patients for whom cardiac catheterization may be inadvisable . Such patients should be considered for direct referral for heart-lung or single lung transplantation on the basis of noninvasive evaluation without cardiac catheterization studies. The decision to accept the risk of cardiac cathet^rization for the purpose of evaluating the effectiveness of or initiating therapy with investigational vasodilating agents (for example, continuous intravenous prostacyclin i24]) should he made on an individual basis .
The results of exercise testing often confirm what is suspected on the basis of clinical judgment . However. exercise testing also allows qualitative clinical assessments to be quantitated and standardized. Such a process may ultimately prove to be useful to physicians who must concern themselves with the difficult issues relating to the care and study of patients with primary pulmonary hypertension .
Conclusions . The exercise capacity of patients with primary pulmonary hypertension correlates well with hemodynamie variables routinely measured during cardiac catheter iz..tion. Mean right atrial pressure is the hemodynamic variable that correlates best with exercise capacity . Patients with primary pulmonary hypertension and severely limited exercise capacity (that is . < 10% of the predicted value) are at high risk for complications during cardiac catheterization . Progressive bicycle ergometry is a safe procedure that can accurately identify these patients, thereby permitting timely consideration of alternative Treatment plans (for example, transplantation without prior cardiac catheterization) . Conversely-an exercise capacity >75%e of the predicted value may identify the subgroup of patients with primary pulmonary hypertension capable of active pulmonary vasodilation ; in past studies (11,21) such patients have been found to be those most likely to benefit from long-term vasodilator ;herapy . Exercise testing, therefore . appears to be a useful addition to the noninvasive evaluation of patients with primary pulmonary hypertension . 
